PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	23.38	25.89	12.89	2.24	2.73
Cash & Short-Term Investments	23.38	25.89	12.89	2.24	2.73
Cash Growth	80.70%	100.87%	474.84%	-17.99%	-
Accounts Receivable	1.18	1.22	0.33	-	-
Inventory	3.05	2.71	1.31	-	-
Other Current Assets	0.09	0.08	0.05	0.08	-
Total Current Assets	27.71	29.89	14.57	2.32	2.73
Net Property, Plant & Equipment	5.44	5.48	4.02	-	-
Other Intangible Assets	11.37	11.6	5.13	-	-
Goodwill	18.61	18.6	11.48	-	-
Total Assets	63.13	65.57	35.21	2.32	2.73

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	2.38	5.2	1.54	0.05	0.02
Current Portion of Long-Term Debt	0.39	0.39	0.08	-	-
Current Portion of Leases	0.15	0.15	0.07	-	-
Other Current Liabilities	0.02	0.06	0.01	-	-
Total Current Liabilities	2.94	5.81	1.7	0.05	0.02
Long-Term Debt	3.07	3.09	0.32	-	-
Long-Term Leases	0.87	0.91	0.49	-	-
Other Long-Term Liabilities	3.43	3.49	2.14	-	-
Total Long-Term Liabilities	7.36	7.49	2.95	-	-
Total Liabilities	10.31	13.3	4.64	0.05	0.02

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	50.95	50.95	31.7	2.8	2.74
Additional Paid-in Capital	4.17	4.11	0.67	0.49	0.52
Retained Earnings	-2.72	-3.14	-2.03	-1.01	-0.54
Total Common Shareholders' Equity	52.39	51.92	30.34	2.27	2.72
Minority Interest	0.43	0.35	0.22	-	-
Shareholders' Equity	52.83	52.27	30.56	2.27	2.72
Total Liabilities & Equity	63.13	65.57	35.21	2.32	2.73

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	4.48	4.55	0.95	0	0
Net Cash (Debt)	18.9	21.34	11.93	2.24	2.73
Net Cash Growth	57.24%	78.82%	432.33%	-17.99%	-
Net Cash Per Share	0.13	0.17	0.15	0.06	0.08
Book Value	52.39	51.92	30.34	2.27	2.72
Book Value Per Share	0.37	0.41	0.37	0.06	0.08
Tangible Book Value	22.41	21.72	13.73	2.27	2.72
Tangible Book Value Per Share	0.16	0.17	0.17	0.06	0.08

Data Source: Fiscal.ai Last updated: Jun 1, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error